Mandible-repositioning antisnoring orthosis
Australia TGA ARTG Registered Device · The Weringa Group Pty Ltd · Vivos Therapeutics Inc · Class I · Started July 15, 2024
Good Name: The Weringa Group Pty Ltd - Mandible-repositioning antisnoring orthosis
- Risk Class
- Class I
- Product Type
- Single Device Product
- ARTG Category
- General
- Start Date
- July 15, 2024
- Effective Date
- July 15, 2024
- Country
- United States of America
- Address
- 300 S 5th Street, Murray, KY, 42071
Intended to be used to reduce nighttime snoring and mild to moderate sleep apnoea in adults.
Access comprehensive regulatory information for Mandible-repositioning antisnoring orthosis in the Australia medical device market through Pure Global AI's free TGA ARTG database. This Class I is sponsored by The Weringa Group Pty Ltd, manufactured by Vivos Therapeutics Inc in United States of America. The device registration started on July 15, 2024.
This page provides complete registration details including sponsor information, manufacturer details, and regulatory compliance data from the official Australia TGA ARTG medical device database. Pure Global AI offers free access to Australia's complete medical device registry with 131,000+ devices, helping global MedTech companies navigate TGA regulations efficiently.